| Literature DB >> 35893545 |
Agnieszka Lachowicz-Wolak1, Małgorzata D Klimowicz-Bodys1, Katarzyna Płoneczka-Janeczko1, Marek Bykowy1, Magdalena Siedlecka1, Jagoda Cinciała2, Krzysztof Rypuła1.
Abstract
Bovine respiratory disease (BRD) is a very important disease that contributes to economic losses in dairy and beef cattle breeding worldwide. The molecular testing of material from 296 calves showing BRD symptoms from 74 dairy herds located in south-western Poland was performed in 2019-2021. Molecular tests were performed using a commercial kit "VetMAXTM Ruminant Respiratory Screening Kit" (Thermo Fisher Scientific) for the simultaneous detection of genetic material of seven pathogens responsible for BRD. At least one pathogen was detected in 95.95% of herds. The overall prevalence was: Pasteurella multocida 87.84%, Mannheimia haemolytica 44.59%, bovine coronavirus (BcoV) 32.43%, Mycoplasma bovis 29.73%, Histophilus somni 28.38%, bovine parainfluenza virus type 3 (BPIV-3) 13.51%, and bovine respiratory syncytial virus (BRSV) 10.81%. Twenty-nine configurations of pathogen occurrences were found. Bacterial infections were the most frequently recorded as 56.7% of all results. Coinfections mainly consisted of two pathogens. Not a single purely viral coinfection was detected. The most frequent result was a single P. multocida infection accounting for 18.31% of all results. The statistically significant correlation (p = 0.001) with the highest strength of effect (ϕ 0.38) was between M. bovis and H. somni.Entities:
Keywords: BRD; PCR detection; cattle; coinfections; pathogen configurations; pathogen correlations; prevalence; respiratory diseases
Year: 2022 PMID: 35893545 PMCID: PMC9332621 DOI: 10.3390/microorganisms10081487
Source DB: PubMed Journal: Microorganisms ISSN: 2076-2607
Figure 1Map of Poland with region marked in gray where tested dairy cattle herds were located.
Figure 2Percentage of infection types in positive results. Virus–virus coinfections were not detected.
Figure 3The overall prevalence of individual pathogens detected.
Figure 4The prevalence of individual pathogens detected depending on the type of sample.
The table shows the correlations between the occurrence of the pathogen pairs studied. Statistically significant correlations and their strength of effect are highlighted in bold. All marked correlations were positive. p denotes statistical significance; ϕ denotes a Phi contingency coefficient indicating the strength of effect of a given association. * denotes that the correlation shown is inverse.
| Correlations | |||||||
|---|---|---|---|---|---|---|---|
| BRSV | BCoV |
|
|
|
| ||
| BPIV-3 |
|
|
| 1.000 | 1.000 | 1.000 | 0.713 |
| ϕ |
|
| 0.04 | 0.03 | 0.01 | 0.08 | |
| BRSV |
| 0.103 | 0.068 * | 0.584 | 0.680 | 0.688 | |
| ϕ | 0.22 | 0.23 * | 0.130 | 0.070 | 0.06 | ||
| BCoV |
| 0.726 | 1.000 |
| 0.311 | ||
| ϕ | 0.04 | 0.01 |
| 0.12 | |||
|
|
| 1.000 | 1.000 |
| |||
| ϕ | <0.01 | 0.02 |
| ||||
|
|
| 1.000 | 0.265 | ||||
| ϕ | 0.05 | 0.15 | |||||
|
|
|
| |||||
| ϕ |
| ||||||
Table showing configurations of pathogens detected, with percentages of occurrence. NS—nasal swabs, TW—tracheal washes.
| Configurations | |||||
|---|---|---|---|---|---|
| No. of Pathogen in Configura-tions | Pathogens Name | No. of Positive Results | % of All Positive Results | ||
| All (71) | NS (45) | TW (26) | |||
| 1 | BCoV | 1 | 1 | 0 | 1.41% |
|
| 2 | 2 | 0 | 2.82% | |
|
| 13 | 9 | 4 | 18.31% | |
| 2 | 1 | 1 | 0 | 1.41% | |
| 1 | 1 | 0 | 1.41% | ||
| 2 | 1 | 1 | 2.82% | ||
| 3 | 3 | 0 | 4.23% | ||
| 10 | 7 | 3 | 14.08% | ||
| 3 | 2 | 1 | 4.23% | ||
| 2 | 0 | 2 | 2.82% | ||
| 3 | BPIV-3, BCoV, | 1 | 1 | 0 | 1.41% |
| BPIV-3, BRSV, | 1 | 1 | 0 | 1.41% | |
| BCoV, | 1 | 0 | 1 | 1.41% | |
| BCoV, | 3 | 3 | 0 | 4.23% | |
| BCoV, | 2 | 1 | 1 | 2.82% | |
| BCoV, | 1 | 0 | 1 | 1.41% | |
| 5 | 3 | 2 | 7.04% | ||
| 1 | 1 | 0 | 1.41% | ||
| 2 | 0 | 2 | 2.82% | ||
| 4 | BPIV-3, BRSV, BCoV, | 1 | 1 | 0 | 1.41% |
| BPIV-3, BCoV, | 2 | 1 | 1 | 2.82% | |
| BRSV, BCoV, | 1 | 0 | 1 | 1.41% | |
| BCoV, | 2 | 1 | 1 | 2.82% | |
| 4 | 1 | 3 | 5.63% | ||
| 5 | BPIV-3, BRSV, BCoV, | 1 | 1 | 0 | 1.41% |
| BPIV-3, BCoV, | 1 | 1 | 0 | 1.41% | |
| BRSV, BCoV, | 1 | 1 | 0 | 1.41% | |
| BCoV, | 2 | 1 | 1 | 2.82% | |
| 6 | not detected | - | - | - | - |
| 7 | BPIV-3, BRSV, BCoV, | 1 | 0 | 1 | 1.41% |
Figure 5Euler diagram with numbers of occurring bacterial infections and bacterial-only coinfections. Common parts indicate the numbers of coinfections in which a common occurrence of pathogens shown was recorded. H. somni and M. bovis did not occur as a single pathogen infection.
Figure 6Area-proportional Euler diagrams with coexistence of the three pairs of pathogens with the highest recorded prevalence. The area of the circle corresponds to the number of occurrences of a given pathogen in coinfections. The common part indicates the number of coinfections in which the co-occurrence of both pathogens shown was recorded, regardless of the rest of the pathogens in the coinfection. (a) Coexistence of P. multocida and M. haemolytica. (b) Coexistence of M. haemolytica and BCoV. (c) Coexistence of P. multocida and BCoV.
Figure 7Area-proportional Euler diagrams with coexistence of the three pairs of pathogens for which the highest statistically significant correlation coefficients were shown overall. The area of the circle corresponds to the number of occurrences of a given pathogen in coinfections. The common part indicates the number of coinfections in which a common occurrence of both pathogens shown was recorded, regardless of the rest of the pathogens in the coinfection. (a) Coexistence of M. bovis and H. somni. (b) Coexistence of BCoV and BPIV-3. (c) Coexistence of BPIV-3 and BRSV.
Figure 8Matrix of Jaccard similarity coefficients (Jaccard index) between all pathogens detected in coinfections. The darker the color, the higher the value of the Jaccard index.